Genocea Biosciences, Inc. (NASDAQ: GNCA), a clinical-stage
biopharmaceutical company developing T cell-directed vaccines and
immunotherapies, today announced that management will present a company
overview at the BioCentury 21 st Annual NewsMakers in the
Biotech Industry Conference.
Binkow & Goldberg LLP announces that it is investigating
potential claims on behalf of investors of ITT
Educational Services Inc. (“ITT” or the “Company”) (NYSE:ESI). The
investigation concerns possible violations of federal securities laws
and focuses on the Company’s operations and financial performance.
Tesla Motors Inc. (TSLA) is on track to meet production goals this year, but concerns about the "aggressive timetable" for battery factory and the money needed to ramp production capacity in future years and to meet other goals are concerns, Goldman Sachs analysts said on Friday.
The Board of Directors of Graco Inc. (NYSE:GGG) has declared a
regular quarterly dividend of 27.5 cents per common share, payable on
November 5, 2014, to shareholders of record at the close of business on
October 20, 2014.
Heartland Payment Systems (NYSE: HPY ),
the nation's fifth largest payments processor and a leading provider of
merchant business solutions, has introduced a feature-rich mobile and
online ordering solution to help restaurants of all sizes remain
plc , (Nasdaq: ICLR), a global provider of outsourced
development services to the pharmaceutical, biotechnology and medical
device industries, announced today that it has completed a $40 million
buyback of the Company’s ordinary shares through open market
acquisitions at an average price of $49.87. In addition, the Company
announced a further program under which the Company can acquire (by way
of redemption) up to an additional $100 million of its outstanding
ordinary shares through open market share acquisitions.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.